These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2218446)

  • 1. [X-chromosomal adrenoleukodystrophy. A peroxisomal disease important for differential diagnosis in the internal medicine-neurological field].
    Wagdi P; Meier C
    Schweiz Med Wochenschr; 1990 Sep; 120(35):1247-52. PubMed ID: 2218446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders.
    Molzer B; Kainz-Korschinsky M; Sundt-Heller R; Bernheimer H
    J Clin Chem Clin Biochem; 1989 May; 27(5):309-14. PubMed ID: 2474624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of peroxisomal disorders with neurological involvement.
    Molzer B
    Padiatr Padol; 1993; 28(1):43-8. PubMed ID: 8446428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of pharmacological induction of fatty acid beta-oxidation in X-linked adrenoleukodystrophy.
    McGuinness MC; Zhang HP; Smith KD
    Mol Genet Metab; 2001; 74(1-2):256-63. PubMed ID: 11592822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisomal fatty acid beta-oxidation in relation to adrenoleukodystrophy.
    Wanders RJ; Tager JM
    Dev Neurosci; 1991; 13(4-5):262-6. PubMed ID: 1817031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy.
    Moser HW; Bergin A; Naidu S; Ladenson PW
    Endocrinol Metab Clin North Am; 1991 Jun; 20(2):297-318. PubMed ID: 1879401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [From gene to disease; X-linked adrenoleukodystrophy].
    Engelen M; Kemp S; van Geel BM
    Ned Tijdschr Geneeskd; 2008 Apr; 152(14):804-8. PubMed ID: 18491823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Very long chain fatty acids in the pathogenesis, prenatal and postnatal diagnosis of X-linked adrenoleukodystrophy].
    Grković S; Dordević M; Nikolić R; Zivancević-Simonović S; Puzigaća Z
    Med Pregl; 2007; 60(7-8):401-3. PubMed ID: 17990810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [X-linked adrenoleukodystrophy and other peroxisomal diseases caused by a failing peroxisomal beta-oxidation system: clinical expression, diagnosis and treatment].
    Wanders RJ; Barth PG; Schutgens RB; Van den Bosch H; Tager JM; Stroink H; Przyrembel H; Heymans HS
    Tijdschr Kindergeneeskd; 1989 Oct; 57(5):186-97. PubMed ID: 2683204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Examination of very long chain fatty acids in diagnosis of x-linked adrenoleukodystrophy].
    Stradomska TJ; Tylki-Szymańska A
    Pediatr Pol; 1996 Mar; 71(3):197-201. PubMed ID: 8966090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: survey of 303 cases: biochemistry, diagnosis, and therapy.
    Moser HW; Moser AE; Singh I; O'Neill BP
    Ann Neurol; 1984 Dec; 16(6):628-41. PubMed ID: 6524872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy.
    Kemp S; Valianpour F; Denis S; Ofman R; Sanders RJ; Mooyer P; Barth PG; Wanders RJ
    Mol Genet Metab; 2005 Feb; 84(2):144-51. PubMed ID: 15670720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Symptomatic heterozygotic adrenoleukodystrophy in adults. 10 cases].
    Ménage P; Carreau V; Tourbah A; Fontaine B; Paturneau-Jouas M; Gout O; Lubetzki C; Baumann N; Lyon-Caen O
    Rev Neurol (Paris); 1993; 149(8-9):445-54. PubMed ID: 8009141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very long chain fatty acids in X-linked adrenoleukodystrophy brain after treatment with Lorenzo's oil.
    Poulos A; Gibson R; Sharp P; Beckman K; Grattan-Smith P
    Ann Neurol; 1994 Nov; 36(5):741-6. PubMed ID: 7979219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new peroxisomal disorder with fetal and neonatal adrenal insufficiency.
    Vanhole C; de Zegher F; Casaer P; Devlieger H; Wanders RJ; Vanhove G; Jaeken J
    Arch Dis Child Fetal Neonatal Ed; 1994 Jul; 71(1):F55-6. PubMed ID: 8092875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisomal fatty acid beta-oxidation in relation to the accumulation of very long chain fatty acids in cultured skin fibroblasts from patients with Zellweger syndrome and other peroxisomal disorders.
    Wanders RJ; van Roermund CW; van Wijland MJ; Schutgens RB; Heikoop J; van den Bosch H; Schram AW; Tager JM
    J Clin Invest; 1987 Dec; 80(6):1778-83. PubMed ID: 3680527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progressive neurologic deterioration in a nine-year-old white male.
    Barness LA; Chandra S; Kling P; Laxova R; Allen DB; Gilbert-Barness E
    Am J Med Genet; 1990 Dec; 37(4):489-503. PubMed ID: 2260594
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adrenoleukodystrophy--clinical, biochemical and therapeutic aspects].
    Skjeldal OH; Strømme P; Christensen E
    Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3321-3. PubMed ID: 7809891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotype heterogeneity among hemizygotes in a family biochemically screened for adrenoleukodystrophy.
    Cotrufo R; Melone MA; Monsurro MR; Di Iorio G; Carella C; Moser HW
    Am J Med Genet; 1987 Apr; 26(4):833-8. PubMed ID: 3591825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Adrenomyeloneuropathy. A frequent cause of Addison's disease].
    Schäfer JR; Ehlenz K; Steinmetz A; Pilz C; Hunneman DH; Baerwald C; von Wichert P; Kaffarnik H
    Dtsch Med Wochenschr; 1994 Mar; 119(10):327-31. PubMed ID: 8125035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.